Trial intelligence / Profile preview

Imidapril vs Candesartan in Mild to Moderate Hypertension

NCT00644475Phase 3Unknown

Sponsor
University of Pavia
Start
Mar 2008
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of imidapril in essential hypertension, sponsored by University of Pavia. Status: unknown.

02

Drugs

imidapril
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT00644475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00644475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call